None listed
Conditions
Interventions
None listed
Sponsors
Kyunghee University-industry Cooperation Foundation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Those who have been diagnosed with COVID-19 and have been quarantined (and cured) for at least one month. 2. Adults between 20 and 65 years of age 3. Those who complain of at least one of the following symptoms that have persisted for more than 4 weeks after being cured of COVID-19, and whose symptom intensity of 4 or higher on the 0-10 numeric rating scale 3-1 Those who complain of fatigue 3-2 Those who complain of orfactory disturbance 3-3 Those who complain of alopecia 3-4 Those who complain of arthralgia 4. Those who voluntarily agree to participate in the study through a written consent form after being clearly explained of the purpose and characteristics of this case series study
Exclusion criteria
Exclusion criteria: 1. Those with the following diseases Those who have a history of diseases or surgical operation that can cause sequelae (fatigue, olfactory disturbance, alopecia, arthralgia etc) before the infection of COVID-19 Fatigue: Those who have been diagnosed as cancer, anemia, hypothyroidism or psychiatric disease such as depression Orfactory disturbance: Those who have been diagnosed as rhinitis, polyp, head and neck cancer, or have had radiotherapy or chemotherapy, or have been exposed to chemicals which affect olfactory sense such as pesticides, and organic solvents Alopecia: Those who have been diagnosed as scalp skin disease or have had follicular unit hair transplantation, radiotherapy or chemotherapy Arthralgia: Those who have been diagnosed as rheumatoid arthritis, cancer, fracture or have had relative orthopedic surgery 1-2 Those who have a fear of acupuncture and moxibustion treatment 2. Women who are pregnant, may become pregnant or are lactating 3. Those who are judged that it is difficult to comply with this treatment protocol, visiting the hospital, or filling in a questionnaire, etc. 4. Those who are participating in another clinical study 5. Subjects who are judged to be inappropriate for the clinical study by the researchers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 0-10 numeric rating scale (NRS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Study design and subject compliance to acupuncture and moxibustion treatment;Selection rate during the study period (%);Fatigue assessement scale (FAS);Fatigue severity scale (FSS);Brief fatigue inventory (BFI));Cross-cultural smell identification test (CC-SIT);Questionnaire of olfactory disorders (QOD);The severity alopecia tool (SALT);Visual evaluation (photo);Brief pain inventory-short form (BPI-SF);EuroQoL-5Dimension-5L (EQ-5D-5L);Measure yourself medical outcome profile (MYMOP2);Concomitant medications and changes in treatment history;Was it Worth It (WIWI) questionnaires;Adverse event evaluation after acupuncture and moxibustion treatment | — |
Countries
Korea, Republic of
Contacts
Public Contactsunoh kwon
Korea Institute of Oriental Medicine
Outcome results
None listed